GlassScriptPhysician profile
Chigozirim Ekeke
NPI 1275911265
$92,399.43
in general payments reported to CMS, 2019-2025
12 companies · $39K in 2025
The $39K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2022: $488 · 2023: $3,272 · 2024: $49K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $72K · Travel and Lodging: $11K · Food and Beverage: $5,022 · Education: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $71,897.02 |
| Travel and Lodging | $11,334.10 |
| Food and Beverage | $5,022.05 |
| Education | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $62,506.28 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Ethicon US, LLC | $16,654.36 | 2024-2025 | Echelon; Endopath, Echelon Flex, Harmonic |
| Intuitive Surgical, INC. | $5,341.22 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $3,431.81 | 2024-2025 | Matrixrib |
| Astrazeneca Pharmaceuticals LP | $1,474.60 | 2024-2025 | Imfinzi, Tagrisso |
| Cook Incorporated | $1,125.00 | 2024 | |
| Medtronic, INC. | $890.36 | 2022-2024 | Signia, Illumisite, Endo Gia Ultra |
| Elucent Medical | $481.70 | 2023 | |
| Davol INC. | $158.41 | 2019 | |
| Edwards Lifesciences Corporation | $145.88 | 2023 | |
| On Target Laboratories, INC | $103.86 | 2025 | Cytalux |
| Depuy Synthes Sales INC. | $85.95 | 2024 | Matrixrib |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chigozirim Ekeke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.